Company / Interest Expense
ACCENDRA HEALTH INC/VA/ Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$107.2M
FY2025
5-year range
$98.1M / $128.9M
FY2021-FY2025
Trend
-0.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has declined for 3 consecutive years, from $129M in FY2022 to $107M in FY2025.
Based on SEC 10-K filings.
$107M in FY2025 with a 5-year CAGR of +5.1%.
Improved from $117M to $107M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -6.0%
- 5-Year CAGR
- +5.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- ACCENDRA HEALTH INC/VA/'s interest expense has declined for 3 consecutive years.
- 5-year CAGR of +5.1%, indicating consistent growth.
- In FY2025, interest expense decreased 0.4% year-over-year.
- Peak interest expense was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $107.2M | -0.4% |
| FY2024 | $107.6M | -7.9% |
| FY2023 | $116.8M | -9.4% |
| FY2022 | $128.9M | +31.4% |
| FY2021 | $98.1M | +17.6% |
| FY2020 | $83.4M | +17.5% |
| FY2019 | $71.0M | +0.0% |
| FY2018 | $71.0M | +123.4% |
| FY2017 | $31.8M | +17.4% |
| FY2016 | $27.1M | -0.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026